๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Uterine Cervical Neoplasms
Clinical trial register · China

Uterine Cervical Neoplasms Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Wuhan 3 Hangzhou 3 Beijing 2 Shanghai 2 Guangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Wuhan3 Hangzhou3 Beijing2 Shanghai2 Guangzhou2
All 12 locations
Target enrolment
to

Uterine Cervical Neoplasms trials in China

13 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
NCT07646301Uterine Cervical Neoplasms, Locally Advanced
Sun Yat-sen University
Phase 2
103
Guangzhou
2026-07-01
Recruiting
Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
NCT07702838Uterine Cervical Neoplasms
Zhejiang Cancer Hospital
Not applicable
30
Hangzhou
2026-07
Not yet open
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642Uterine Cervical Neoplasms, Triple Negative Breast Neoplasms, Prostatic Neoplasms, Squamous Cell Carcinoma of Head and Neck
GV20 Therapeutics
Phase 2
227
Beijing, Harbin
2026-06-02
Not yet open
Patient Journey in Advanced Gynecologic Cancers
NCT07015593Genital Neoplasms, Female, Uterine Cervical Neoplasms, Endometrial Carcinoma
Tongji Hospital
Observational
780
Hefei, Guangzhou, Wuhan, Chongqing
2025-07-01
Recruiting
Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis
NCT06840418Uterine Cervical Neoplasms
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
15
Shanghai
2025-01-01
Recruiting
Neoadjuvant Therapy in Cervical Cancer
NCT06558682Uterine Cervical Neoplasms
Qilu Hospital of Shandong University
Not applicable
48
Jinan
2024-10-20
Not yet open
A Prospective Cohort Study Comparing AI Prediction Model With Imaging Assessment to Diagnose Lymph Node Metastasis in Cervical Cancer
NCT06541288Uterine Cervical Neoplasms
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
230
Shanghai
2024-08
Recruiting
Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
NCT05735145Uterine Cervical Neoplasms, Chemoradiotherapy, Adjuvant Chemotherapy
Fourth Affiliated Hospital of Guangxi Medical University
Phase 3
108
Liuzhou
2022-07-01
Recruiting
Retrospective Study of Brachytherapy
NCT05242861Brachytherapy, Uterine Cervical Neoplasms, Uterine Neoplasms, Vulvar Cancer
Zhejiang Cancer Hospital
Observational
300
Hangzhou
2022-02-20
Active, closed
Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix
NCT06771596Uterine Cervical Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
43
Beijing
2021-05-12
Recruiting
Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
NCT04733820Uterine Cervical Neoplasms, Cervical Cancer
Huazhong University of Science and Technology
Phase 3
340
Wuhan
2021-02-01
Active, closed
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
NCT04723875Uterine Cervical Neoplasms, Cervical Cancer
Huazhong University of Science and Technology
Phase 3
306
Wuhan, Ji'nan, Hangzhou
2021-01-28
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/uterine-cervical-neoplasms

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Uterine Cervical Neoplasms.

How many Uterine Cervical Neoplasms trials are recruiting in China?

8 of the 13 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Uterine Cervical Neoplasms), 13 studies
PhaseStudiesRecruitingShare
Not applicable4330.8%
Phase 23123.1%
Phase 33223.1%
Observational2115.4%
Phase 4117.7%

Most active sponsors

Lead sponsors with the most studies (Uterine Cervical Neoplasms)
Lead sponsorStudiesRecruiting
Huazhong University of Science and Technology21
Obstetrics & Gynecology Hospital of Fudan University21
Zhejiang Cancer Hospital22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences10
Fourth Affiliated Hospital of Guangxi Medical University11
GV20 Therapeutics10
Qilu Hospital of Shandong University11
Sun Yat-sen University11
Tianjin Medical University Cancer Institute and Hospital11
Tongji Hospital10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.